Add BrightSurf on Google Email

Mundo Sano España


Africa–Europe research consortium targets evidence gap keeping young children out of parasite control programs

The IVM-KIDS project aims to address the evidence gap for ivermectin use in children under 15 kg, a population excluded from parasite control programs due to lack of safety evidence. The four-year initiative will conduct clinical research to determine the safety and efficacy of ivermectin in this age group.

SourceMundo Sano España·TypeRandomized controlled/clinical trial·DateSep 23, 2026

Innovative treatment for parasites affecting 1.5 billion people shows safety and superior efficacy in phase II-III trial

A novel drug combination of albendazole and ivermectin demonstrates superior efficacy in treating Trichuris trichiura and other soil-transmitted helminths. The treatment has shown safety in a phase II-III trial, potentially aiding endemic countries in meeting the WHO's Roadmap for Neglected Tropical Diseases.

SourceMundo Sano España·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateJan 10, 2025